NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Nexentis Technologies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.64−0.00 (-0.73%)
Close on Oct 19, 2026
- Market cap
- $522.65K
- P/E (TTM)
- –
- Dividend yield
- –
Nexentis Technologies Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Central America [Member] | – | – | – | – | $221.03K | $20.33K | – | – | – | – |
| United States | – | $171.00K | $142.00K | $163.64K | $201.46K | $211.95K | – | – | – | – |
| Israel | – | $31.00K | $10.00K | $30.00K | $15.66K | – | – | – | – | – |
| Mexico | – | – | $110.00K | $154.43K | $221.03K | – | – | – | – | – |
| Türkiye | – | – | $1.00K | $45.94K | – | – | – | – | – | – |
| Peru | – | $8.00K | – | – | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Nexentis Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.